Avenue Therapeutics, Inc. ATXI

Full chart Compare
Set alert

Price alert · ATXI

All alert types
0.40 USD -0.03 (-6.07%)

At closeNov 3, 2026, 4:00 PM EST

0.40 0.00 -0.52%

After hours · Nov 3, 4:00 PM ET

0.40 Day range 0.40
0.15 52-week range 0.95697
YTD
-40.92%
1 year
-49.07%

Ownership

Held by insiders 9.85%
Held by institutions 10.33%
Float held by institutions 11.46%
Institutions 9

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Armistice Capital, LLC5.60%115,000197.80KSep 29, 2024
Sabby Management, LLC3.07%63,060108.46KSep 29, 2024
Moss Adams Wealth Advisors LLC 0.54%11,00018.92KSep 29, 2024
UBS Group AG0.30%6,14310.56KSep 29, 2024
Tower Research Capital LLC (TRC)0.08%1,7402.99KSep 29, 2024
Wells Fargo & Company0.03%561964Sep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.32%6,59311.34KOct 30, 2024
Fidelity Series Total Market Index Fund0.08%1,5842.72KOct 30, 2024
Vanguard Extended Market Index Fund0.03%6181.06KSep 29, 2024
ATXI insiders
InsiderRelationLatest transactionDateShares held
DAVIDOW ROBERT LBeneficial Owner of more than 10% of a Class of SecuritySaleDec 10, 20230
FORTRESS BIOTECH, INC.Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Apr 15, 20243,547,390
HERSKOWITZ NEILDirectorSaleDec 1, 202497
JIN DAVIDChief Operating OfficerStock Award(Grant)Sep 22, 202465,000
KRANZLER JAY DDirectorSaleNov 4, 2024559
MACLEAN ALEXANDRA M.D.Chief Executive OfficerStock Award(Grant)Sep 22, 2024170,000